FDA Approves New Drug To Protect Babies And Toddlers From RSV
Last year, a surge in RSV cases flooded U.S. hospitals with wheezing children.
Stay updated with breaking news from John Farley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Last year, a surge in RSV cases flooded U.S. hospitals with wheezing children.
U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year. The Food and Drug Administration on
U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year.
A treatment to prevent RSV in children up to two years old has been approved by the US Food and Drug Administration